CD Genomics employs next-generation high-throughput sequencing technology to sequence the transcriptomes of prokaryotes (bacteria and archaea), enabling comprehensive and rapid acquisition of the complete transcriptomic information (including mRNA and non-coding RNA) from individual microbial colonies or microbial communities.
RNA-seq analysis is an advanced technique for studying the bacterial transcriptome in detail. Unlike eukaryotic mRNA, bacterial mRNA lacks a poly(A) tail, requiring specialized methods for library preparation. This technique enables precise measurement of gene expression, discovery of new transcripts, and investigation of gene regulation. In prokaryotes, where transcription and translation happen simultaneously, RNA-seq captures gene expression in specific environments, helping identify key functional genes in metabolic and regulatory pathways.
The bacterial transcriptome is complex, featuring polycistronic mRNAs that encode multiple proteins. This complexity, along with the short lifespan of bacterial mRNAs and potential overlaps, demands specialized analysis tools. RNA-seq provides insights into operon structures, the role of non-coding RNAs, and the dynamics of gene expression, which are crucial for understanding bacterial physiology and pathogenicity.
Prokaryotic RNA sequencing is a powerful, high-throughput technology designed to capture and analyze the RNA transcripts present in bacterial cells at a specific time point. Unlike eukaryotic RNA sequencing, which frequently relies on the presence of a poly(A) tail for mRNA isolation, prokaryotic RNA sequencing employs rRNA depletion methodologies to enrich for mRNA and other non-coding RNAs. This strategy enables a comprehensive analysis of the bacterial transcriptome, encompassing coding and non-coding regions, antisense transcripts, and regulatory elements.
At CD Genomics, our prokaryotic RNA sequencing platform leverages cutting-edge Illumina HiSeq (PE150) and PacBio SMRT systems to deliver high-resolution insights into bacterial gene expression. This platform is versatile, catering to both well-established strains with reference genomes and novel strains lacking genomic information. The data generated through this technology can be applied to a variety of research pursuits, including gene function annotation, differential gene expression analysis, and the elucidation of key regulatory networks within bacterial systems.
Prokaryotic RNA sequencing has a wide range of applications across various fields:
The prokaryotic RNA sequencing workflow at CD Genomics involves several essential steps. It begins with total RNA extraction and quality assessment, followed by rRNA depletion to enrich for mRNA and non-coding RNAs. The remaining RNA is converted to cDNA with strand specificity using dUTP, and then amplified with sequencing adapters. Sequencing is performed using either Illumina for short reads or PacBio for longer reads. Finally, CD Genomics conducts bioinformatics analysis for quality control, transcript assembly, differential gene expression analysis, and functional annotation, utilizing advanced tools like Rockhopper 2 to address the complexities of prokaryotic transcriptomes.
Note: The above content includes only a portion of the bioinformatics analysis. For more information or to customize the analysis, please contact us directly.
Our bioinformatics analysis includes these parts: read QC and assembly, expression analysis, structure analysis, and advanced analysis. For more detailed bioinformatics analysis, please refer to the following table.
Read QC & Assembly | |
---|---|
Quality assessment of raw data | Contamination detection |
Mapping to the reference genome | De novo assembly |
Structure analysis | |
Prediction of novel transcripts | UTR analysis and annotation |
SNP and indel analysis | Operon analysis |
sRNA analysis | Prediction of antisense transcripts |
Gene fusion discovery | |
Expression analysis | |
GO/KEGG enrichment analysis | Cluster analysis |
Gene expression quantification | New gene sequence annotation |
PCA | Alternative splicing analysis |
Advanced analysis | |
Metabolic pathway integration analysis | Gene co-expression network analysis |
Protein interaction network analysis | mRNA-sRNA co-expression network analysis |
Correlation analysis |
Reference-based prokaryotic transcriptome analysis workflow:
Sample Type | Recommended Quantity |
---|---|
Total RNA | ≥ 1 µg |
Cells | ≥ 1×107 |
Note: If you wish to obtain more accurate and detailed information regarding sample requirements, please feel free to contact us directly.
Partial results of our Prokaryotic RNA Sequencing service are shown below:
Please feel free to reach out if you have any further inquiries or require additional information.
Genetic Determinants of Acinetobacter baumannii Serum-Associated Adaptive Efflux-Mediated Antibiotic Resistance
Journal: Antibiotics
Impact factor: 4.3
Published: 11 July 2023
Backgrounds
In 2019, antibiotic-resistant bacteria caused 2.8 million infections and 35,000 deaths in the U.S., with A. baumannii emerging as a significant pathogen showing rapid increases in multidrug resistance. The phenomenon of adaptive efflux-mediated resistance (AEMR) allows laboratory-defined antibiotic-susceptible strains to resist treatment in host conditions. This study aimed to identify genetic determinants contributing to AEMR in A. baumannii by screening a transposon mutant library for loss of serum-associated efflux-mediated resistance.
Materials & Methods
Sample preparation:
Method:
Results
The study investigated the role of the YhaK protein in A. baumannii's adaptive efflux-mediated resistance (AEMR) by performing RNA sequencing on wild-type and YhaK-mutant cells grown in human serum. Results showed that YhaK is upregulated in serum conditions, influencing the expression of 653 genes, with notable effects on transcription, cell signaling, and transport processes. The findings suggest that YhaK may modulate AEMR through various mechanisms, potentially involving the regulation of efflux pumps and post-translational modifications, indicating its importance in A. baumannii's resistance phenotype. Additionally, mutations in YhaK could serve as a tool for further elucidating the genetic determinants of AEMR in this pathogen.
Figure 1. A. baumannii WT and YhaK Tn Transcriptome analysis: KEGG gene ontology groups.
Figure 2. A. baumannii WT and YhaK Tn Transcriptome analysis: differentially expressed genes.
Conclusions
The antibiotic resistance of Acinetobacter baumannii is predominantly attributed to mutations that result in the overexpression of one or more of its 40 putative efflux pump systems. This study significantly contributes to the understanding of the molecular mechanisms underlying efflux pump-mediated antibiotic resistance in A. baumannii, and it holds substantial implications for the future development of antibiotics and antimicrobial therapies.
Reference
Young M, Chojnacki M, Blanchard C, et al. Genetic Determinants of Acinetobacter baumannii Serum-Associated Adaptive Efflux-Mediated Antibiotic Resistance. Antibiotics. 2023, 12(7):1173.
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.
Please fill out the form below: ×